10 Things Worth Pay...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$88.58 0.49 | 0.56%
06/04/12 - 04:02 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 2.41B | 1.99B | 1.95B | 1.11B |
| Receivables | 730.60M | 647.30M | 576.60M | 538.40M |
| Inventories | 249.70M | 229.40M | 213.90M | 262.50M |
| Other Current Assets | 482.00M | 376.70M | 368.70M | 40.90M |
| Total Current Assets | 4.05B | 3.99B | 3.11B | 2.27B |
| Property, Plant & Equipment, Gross | 1.53B | 1.45B | 1.37B | 1.28B |
| Accumulated Depreciation & Depletion | 722.20M | 646.70M | 559.20M | 501.10M |
| Property, Plant & Equipment, Net | 807.00M | 800.60M | 808.10M | 774.10M |
| Intangibles | 1.17B | 996.00M | 1.36B | 1.49B |
| Other Non-Current Assets | 247.10M | 261.40M | 266.70M | 272.90M |
| Total Non-Current Assets | 4.46B | 4.31B | 4.43B | 4.52B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 8.51B | 8.31B | 7.54B | 6.79B |
| Accounts Payable | 200.40M | 222.50M | 204.00M | 173.90M |
| Short Term Debt | 0.00 | 642.50M | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 16.10M | 42.50M | 49.40M |
| Total Current Liabilities | 955.00M | 1.53B | 811.60M | 697.00M |
| Long Term Debt | 1.52B | 1.53B | 1.49B | 1.64B |
| Deferred Income Taxes | 0.00 | 0.00 | 1.40M | 44.10M |
| Other Non-Current Liabilities | 705.80M | 464.40M | 388.40M | 402.80M |
| Minority Interest | 3.60M | 4.30M | 2.50M | 1.60M |
| Total Non-Current Liabilities | 2.24B | 2.02B | 1.90B | 2.08B |
| Total Liabilities | 3.20B | 3.55B | 2.71B | 2.78B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 5.31B | 4.76B | 4.82B | 4.01B |
| Common Par | 3.10M | 3.10M | 3.10M | 3.10M |
| Additional Paid In Capital | 2.76B | 2.82B | 2.73B | 2.52B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 2.97B | 2.23B | 2.36B | 1.88B |
| Treasury Stock | -183.20M | -133.90M | -164.50M | -192.40M |
| Other Equity Adjustments | -241.40M | -152.90M | -102.80M | -198.70M |
| Total Capitalization | 6.82B | 6.29B | 6.31B | 5.65B |
| Total Equity | 5.31B | 4.76B | 4.82B | 4.01B |
| Total Liabilities & Stock Equity | 8.51B | 8.31B | 7.54B | 6.79B |
| Total Common Shares Outstanding | 305.27M | 305.52M | 304.43M | 304.48M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 2.25M | 1.99M | 3.08M | 3.42M |
| Basic Weighted Shares Outstanding | 304.40M | 303.40M | 303.60M | 304.10M |
| Diluted Weighted Shares Outstanding | 310.20M | 308.00M | 305.80M | 306.40M |
| Number of Employees | 10000 | 9200 | 8300 | 8740 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AGN
- Portfolio NameUser Type
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
- Contributor10 Pharmaceutical Stocks Wi...
- ContributorCramer's Openings in Health...
- ContributorCramer's Vice and Vanity St...
Latest AGN Headlines from TheStreet
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.21.12 | 09:05 am
- Ex-Dividend Stocks: Thomson Reuters, Infosys 05.21.12 | 05:05 am
- Cramer's 'Mad Money' Recap: 7 Stocks to Scoop Up When On Sale 05.09.12 | 08:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Winner 05.03.12 | 05:05 pm
- Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 04:05 pm
- 3 Stocks I Saw on TV, May 2
05.02.12 | 08:05 am - The Week Ahead: Jobs Data; Earnings from MasterCard, Visa, Whole Foods 04.29.12 | 06:04 pm
- Allergan Stock Hits New 52-Week High (AGN) 04.26.12 | 01:04 pm
- 3 Stocks I Saw on TV, April 13 04.13.12 | 08:04 am
- Cramer's 'Mad Money' Recap: Love and Hip Stocks (Final) 04.12.12 | 06:04 pm
Press Releases for AGN
- Allergan Reports First Quarter 2012 Operating Results - Business Wire 05.02.12 | 09:05 am
- BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary Of U.S. Food And Drug Administration Approval - Business Wire 04.13.12 | 09:04 am
- Allergan Announces Quarterly Conference Call - Business Wire 04.06.12 | 01:04 pm
- Allergan Announces Positive Top-Line Results From Phase III BOTOX® Overactive Bladder Program - Business Wire 03.28.12 | 09:03 am
- U.S. Federal Court Finds In Favor Of Allergan, Inc. And Issues Permanent Injunction Against Merz Pharmaceuticals And Merz Aesthetics - Business Wire 03.12.12 | 09:03 am
- Allergan Announces Research & Development Technology Review - Business Wire 02.15.12 | 04:02 pm
- Allergan Reports Fourth Quarter 2011 Operating Results - Business Wire 02.02.12 | 09:02 am
- Allergan Announces Quarterly Conference Call - Business Wire 01.06.12 | 06:01 pm
- Actress Christina Hendricks Urges Women To Join Her In The Final Weeks Of The LATISSE® Wishes Challenge To Increase Money Raised For The Make-A-Wish Foundation® From $390,000 To Campaign Goal Of $500,000 - PR Newswire 11.09.11 | 08:11 am
- Allergan Reports Third Quarter 2011 Operating Results - Business Wire 10.26.11 | 09:10 am
Partner Headlines for AGN
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Cracker Barrel and Other Stocks Insiders Are Buying - Benzinga 04.06.12 | 06:04 am
- Court Deals Blow to Botox Competitor - Analyst Blog - Zacks 03.16.12 | 05:03 pm
- MAP Pharma: Making Money From Migraines - Seeking Alpha 03.11.12 | 09:03 am
- Cramer's Mad Money - 15 Things To Watch This Week (1/27/12) - Seeking Alpha 01.29.12 | 07:01 am
- 6 Drug Companies Favored By Hedge Funds - Seeking Alpha 01.05.12 | 09:01 am
- ETF Showdown: Fun With Pharma - Benzinga 12.30.11 | 04:12 pm
- A Look At Atalanta Sosnoff Capital's Top Buys - Seeking Alpha 11.17.11 | 08:11 am
- Medicis Misses Zacks Consensus - Analyst Blog - Zacks 11.11.11 | 10:11 am
- A Look at The New DRGS ETN - Benzinga 10.31.11 | 01:10 pm
